- Home
- FEMY vs CYN Comparison
FEMY vs CYN Comparison
Compare FEMY & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEMY
- CYN
- Stock Information
- Founded
- FEMY 2004
- CYN 2013
- Country
- FEMY United States
- CYN United States
- Employees
- FEMY N/A
- CYN N/A
- Industry
- FEMY Medical/Dental Instruments
- CYN EDP Services
- Sector
- FEMY Health Care
- CYN Technology
- Exchange
- FEMY Nasdaq
- CYN Nasdaq
- Market Cap
- FEMY 29.9M
- CYN 28.0M
- IPO Year
- FEMY 2021
- CYN 2021
- Fundamental
- Price
- FEMY $0.92
- CYN $9.12
- Analyst Decision
- FEMY Strong Buy
- CYN
- Analyst Count
- FEMY 3
- CYN 0
- Target Price
- FEMY $8.67
- CYN N/A
- AVG Volume (30 Days)
- FEMY 257.9K
- CYN 12.8M
- Earning Date
- FEMY 08-07-2025
- CYN 08-06-2025
- Dividend Yield
- FEMY N/A
- CYN N/A
- EPS Growth
- FEMY N/A
- CYN N/A
- EPS
- FEMY N/A
- CYN N/A
- Revenue
- FEMY $1,699,232.00
- CYN $409,777.00
- Revenue This Year
- FEMY $283.83
- CYN $1,162.03
- Revenue Next Year
- FEMY $161.03
- CYN $427.83
- P/E Ratio
- FEMY N/A
- CYN N/A
- Revenue Growth
- FEMY 61.97
- CYN N/A
- 52 Week Low
- FEMY $0.69
- CYN $3.62
- 52 Week High
- FEMY $1.80
- CYN $1,312.50
- Technical
- Relative Strength Index (RSI)
- FEMY 46.22
- CYN 51.17
- Support Level
- FEMY $0.91
- CYN $9.00
- Resistance Level
- FEMY $0.99
- CYN $12.22
- Average True Range (ATR)
- FEMY 0.05
- CYN 4.16
- MACD
- FEMY 0.00
- CYN -0.44
- Stochastic Oscillator
- FEMY 11.71
- CYN 0.96
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
About CYN Cyngn Inc.
Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.